Inter Pharma Public Company Limited (BKK: IP)

IP Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,793	1,781	1,523	908.63	442.1	371.33
Other Revenue	15.97	17.54	11.12	12.35	4.84	4.56
Revenue	1,809	1,799	1,534	920.98	446.94	375.88
Revenue Growth (YoY)	1.92%	17.23%	66.61%	106.07%	18.90%	18.36%
Cost of Revenue	1,144	1,122	905.42	507.85	182.77	157.39
Gross Profit	665.39	676.98	629.03	413.14	264.17	218.5
Selling, General & Admin	607.42	567.58	458.23	267.36	187.22	156.73
Operating Expenses	607.42	567.58	458.23	267.36	187.22	156.73
Operating Income	57.98	109.4	170.8	145.77	76.95	61.77
Interest Expense	-22.51	-25.76	-23.34	-8.01	-1.14	-0.59
Earnings From Equity Investments	-2.3	-2.27	-0.77	-0.08	-0.16	-0.22
EBT Excluding Unusual Items	33.16	81.37	146.69	137.68	75.65	60.95
Pretax Income	33.16	81.37	146.69	137.68	75.65	60.95
Income Tax Expense	11.72	22.47	19.41	27.2	16.39	13.82
Earnings From Continuing Operations	21.44	58.9	127.29	110.48	59.26	47.13
Minority Interest in Earnings	-1.05	-8.11	-8.4	-5.27	-6.72	-3.66
Net Income	20.39	50.79	118.88	105.22	52.54	43.47
Net Income to Common	20.39	50.79	118.88	105.22	52.54	43.47
Net Income Growth	-81.16%	-57.28%	12.99%	100.27%	20.85%	46.47%
Shares Outstanding (Basic)	605	605	532	475	470	356
Shares Outstanding (Diluted)	605	605	532	475	470	356
Shares Change (YoY)	2.16%	13.78%	11.97%	1.05%	31.92%	40.33%
EPS (Basic)	0.03	0.08	0.22	0.22	0.11	0.12
EPS (Diluted)	0.03	0.08	0.22	0.22	0.11	0.12
EPS Growth	-81.56%	-62.45%	0.91%	98.19%	-8.39%	4.37%
Free Cash Flow	20.6	14.96	115.72	-265.73	-21.27	4.41
Free Cash Flow Per Share	0.03	0.02	0.22	-0.56	-0.05	0.01
Dividend Per Share	0.021	0.021	0.111	-	0.010	0.081
Dividend Growth	-80.69%	-80.69%	-	-	-87.33%	107.93%
Gross Margin	36.78%	37.64%	40.99%	44.86%	59.11%	58.13%
Operating Margin	3.20%	6.08%	11.13%	15.83%	17.22%	16.43%
Profit Margin	1.13%	2.82%	7.75%	11.42%	11.75%	11.57%
Free Cash Flow Margin	1.14%	0.83%	7.54%	-28.85%	-4.76%	1.17%
EBITDA	95.94	167.66	208.7	170.85	82.14	63.62
EBITDA Margin	5.30%	9.32%	13.60%	18.55%	18.38%	16.93%
D&A For EBITDA	37.96	58.25	37.9	25.08	5.19	1.85
EBIT	57.98	109.4	170.8	145.77	76.95	61.77
EBIT Margin	3.20%	6.08%	11.13%	15.83%	17.22%	16.43%
Effective Tax Rate	35.34%	27.61%	13.23%	19.75%	21.67%	22.68%
Revenue as Reported	1,809	1,799	1,534	920.98	446.94	375.88
Advertising Expenses	-	70.61	31.91	41.13	36.63	19.94

Source: S&P Capital IQ. Standard template. Financial Sources.